RIAS
DFTX

Rachor Investment Advisory Services’s Definium Therapeutics DFTX Stock Holding History

Rachor Investment Advisory Services’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18K Hold
25
– – ﹤0.01% 173
2026
Q1 		$473 Hold
25
– – ﹤0.01% 386
2025
Q4 		$335 Buy
+25
New +$309 ﹤0.01% 372

Other funds holding DFTX

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Rachor Investment Advisory Services's DFTX Position: Q2 2026 in Review

Rachor Investment Advisory Services held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 25 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #173.

Rachor Investment Advisory Services first reported a position in DFTX in Q4 2025 and has held it in 3 quarters since. 115 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Rachor Investment Advisory Services held 25 shares of Definium Therapeutics worth $1.18K as of Q2 2026.
  • Rachor Investment Advisory Services left its Definium Therapeutics share count unchanged in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Rachor Investment Advisory Services's portfolio in Q2 2026, its #173 holding.
  • Rachor Investment Advisory Services first reported a position in Definium Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 115 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.